OXGENE helps solve the challenge of scalable manufacture for Gene Therapy. Our production platforms and cGMP-compliant cell lines accelerate the development of novel therapeutics.
OXGENE redefines possible in mammalian cell engineering. Our technologies target challenging membrane proteins and facilitate downstream antibody manufacture.
OXGENE integrates biology, informatics, and automation to create a streamlined workflow to meet the ever increasing demand for custom cell line manufacture and generation of complex disease models.